Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
5,817
Total Claims
$338K
Drug Cost
844
Beneficiaries
$400
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 2,621 Pain Management providers
+94%
Opioid rate vs peers
79.9% vs 41.3% avg
0%
Cost per patient vs peers
$400 vs $399 avg
+27%
Brand preference vs peers
4.8% vs 3.8% avg
Opioid Prescribing
79.9%
Opioid Rate
4,647
Opioid Claims
$304K
Opioid Cost
20.9%
Long-Acting Rate
This provider's opioid prescribing rate of 79.9% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 277 claims · $120K
Generic: 5,540 claims · $218K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Hydrocodone/Acetaminophen | 2,161 | $79K |
| Oxycodone Hcl/Acetaminophen | 824 | $40K |
| Oxycodone Hcl | 71 | $40K |
| Oxycodone Myristate | 39 | $26K |
| Buprenorphine | 31 | $25K |
| Fentanyl | 159 | $23K |
| Buprenorphine | 71 | $21K |
| Morphine Sulfate | 489 | $17K |
| Tapentadol Hcl | 16 | $14K |
| Oxycodone Hcl | 300 | $9,104 |
| Pregabalin | 151 | $7,000 |
| Naloxegol Oxalate | 11 | $6,553 |
| Gabapentin | 211 | $4,141 |
| Cyclobenzaprine Hcl | 244 | $3,039 |
| Morphine Sulfate | 73 | $2,002 |
Prescribing Profile
28
Unique Drugs
17.0
Anomaly Score
Patient Profile
68
Avg Age
62%
Female
1.66
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About